Robert C. Mercer, PhD

Research Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published 9/26/2024

    Gojanovich AD, Le NTT, Mercer RCC, Park S, Wu B, Anane A, Vultaggio JS, Mostoslavsky G, Harris DA. Abnormal synaptic architecture in iPSC-derived neurons from a multi-generational family with genetic Creutzfeldt-Jakob disease. Stem Cell Reports. 2024 Oct 08; 19(10):1474-1488. PMID: 39332406.

    Read at: PubMed

  • Published 5/14/2024

    Mercer RCC, Le NTT, Fraser DG, Houser MCQ, Beeler AB, Harris DA. Sigma Receptor Ligands Are Potent Antiprion Compounds that Act Independently of Sigma Receptor Binding. ACS Chem Neurosci. 2024 Jun 05; 15(11):2265-2282. PMID: 38743607.

    Read at: PubMed

  • Published 11/29/2023

    Mercer RCC, Le NTT, Houser MCQ, Beeler AB, Harris DA. Sigma receptor ligands are potent anti-prion compounds that act independently of sigma receptor binding. bioRxiv. 2023 Nov 29. PMID: 38077011.

    Read at: PubMed

  • Published 9/7/2022

    Mercer RCC, Harris DA. Mechanisms of prion-induced toxicity. Cell Tissue Res. 2023 Apr; 392(1):81-96. PMID: 36070155.

    Read at: PubMed

  • Published 1/23/2019

    Mercer RC, Harris DA. Identification of anti-prion drugs and targets using toxicity-based assays. Curr Opin Pharmacol. 2019 02; 44:20-27. PMID: 30684854.

    Read at: PubMed

Education

  • University of Alberta, PhD
  • Memorial University of Newfoundland, MSc
  • Memorial University of Newfoundland, BSc